PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds

Sponsor
Royal College of Surgeons, Ireland (Other)
Overall Status
Recruiting
CT.gov ID
NCT05977816
Collaborator
(none)
2,000
12
2
35.6
166.7
4.7

Study Details

Study Description

Brief Summary

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.

Condition or Disease Intervention/Treatment Phase
  • Device: Negative Pressure Wound Therapy
  • Other: Standard wound dressing
N/A

Detailed Description

NPWT dressings are designed to remove and absorb any fluid leaking from the wound. This might reduce surgical site infections, improve wound healing and improve scar appearance compared to using standard dressings.

Data is limited in the application of NPWT dressings to laparotomy incisions in the acute and elective care surgery setting. Surgical site infections can complicate a patient's post-operative course significantly, often necessitating a longer length of stay, antibiotic therapy, intervention for wound collections and impair patient mobility and overall recovery.

In addition to this, laparotomy wound complications can possibly delay adjuvant therapy and also increases healthcare costs both as an inpatient and in the community. Despite significant measures to reduce such complications in the form of wound care bundles, changing of gloves prior to wound closure etc., surgical site complications continue to represent a huge healthcare burden.

The Investigators are conducting this study to determine whether NPWT dressings reduce surgical site infections, improve wound healing and scar appearance. This study will also involve a cost-based analysis and seek information from patients on their quality of life. Results from this study will provide evidence on whether these dressings should be used as standard of care for management of surgical laparotomy wounds.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel AssignmentParallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
PROPEL-2 Prophylactic Negative Pressure Wound Therapy (NPWT) in Laparotomy Wounds: a Randomised Controlled Trial Comparing Negative Pressure Wound Therapy to Standard Wound Management in Patients Following Midline Laparotomy
Actual Study Start Date :
Jul 14, 2023
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Negative Pressure Wound Therapy

The wound is dressed using negative pressure wound therapy.

Device: Negative Pressure Wound Therapy
Application of a negative wound pressure therapy dressing to the wound post laparotomy

Active Comparator: Standard Wound dressing

After the skin is closed, the wound is covered using sterile standard gauze dressing.

Other: Standard wound dressing
Application of a standard wound dressing to the wound post laparotomy

Outcome Measures

Primary Outcome Measures

  1. Rate of Surgical Site Infection (SSI) [1 month following surgery]

    To compare the rate of surgical site infections within 1 month of the surgical procedure, using Negative Pressure Wound Therapy compared to standard dressings. SSIs will be classified according to Centre for Disease Control (CDC) criteria.

  2. Rate of Surgical Site Infection (SSI) [3 months following surgery]

    To compare the rate of surgical site infections within 3 months of the surgical procedure, using Negative Pressure Wound Therapy compared to standard dressings. SSIs will be classified according to Centre for Disease Control (CDC) criteria.

  3. Rate of Surgical Site Infection (SSI) [6 months following surgery]

    To compare the rate of surgical site infections within 6 months of the surgical procedure, using Negative Pressure Wound Therapy compared to standard dressings. SSIs will be classified according to Centre for Disease Control (CDC) criteria.

Secondary Outcome Measures

  1. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L) [Baseline]

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

  2. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L) [1 month following surgery]

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

  3. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L) [3 months following surgery]

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

  4. Health-related quality of life with the EuroQol-5 dimensions five level index questionnaire (EQ-5D-5L) [6 months following surgery]

    The questionnaire covers five dimensions of health: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Each dimension has 5 levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4) and extreme problems (5). The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. The raw scores are also converted to an EQ-5D index value using a scoring algorithm (British tariff) ranging from -0.594 (worst perceived health state) to 1.00 (best perceived health state)

  5. Scar assessment - using the Patient and Observer Scar Assessment Scale (POSAS) [1 month following surgery]

    The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6

  6. Scar assessment - using the Patient and Observer Scar Assessment Scale (POSAS) [3 months following surgery]

    The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6

  7. Scar assessment - using the Patient and Observer Scar Assessment Scale (POSAS) [6 months following surgery]

    The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6

  8. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ) [1 month]

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

  9. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ) [3 months]

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

  10. Health-related out-of- Pocket Costs assessed using the Costs for Patients Questionnaire (CoPaQ) [6 months]

    The CoPaQ measures patient and caregivers out-of-pocket expenses (direct and indirect) associated with a health condition

  11. Health Economics evaluation of resource use and cost effectiveness using Negative Pressure Wound Therapy dressings [6 months]

    Investigating resource use and cost effectiveness of single-use, prophylactic negative pressure wound therapy versus standard dressings for midline laparotomy wounds based on length of hospital stay and costs of dressings

  12. Healthcare incremental cost- utility ratio [6 months]

    The incremental cost-effectiveness ratio at 6 months for NPWT vesus standard dressings for patients undergoing laparotomy.The effectiveness will be expressed as quality adjusted life years (QALYs) in a cost-utility analysis. QALYs are a composite measure of outcomes where utilities for health states (on 0-1 scale, where 0 corresponds to death and 1 to full health) act as qualitative weights to combine quantity and quality of life. The number of QALYs in each group will be assessed with the EuroQol 5 Dimensions questionnaire (EQ5D). The EQ-5D measures health status in terms of mobility, self-care, usual activities, pain/discomfort and anxiety/depression

  13. Healthcare cost-effectiveness ratio at 6 months [6 months]

    Assessment of the cost-effectiveness ratio at 6 months between NPWT dressings compared to standard dressings. The criteria of effectiveness used will be; Length of hospital stay, requirement for return to theatre, requirement for critical care and number of dressings used

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 18 years or older

  • Patient requires visceral abdominal surgery via a midline laparotomy

  • Patients who can complete questionnaires

Exclusion Criteria:

• Patients who are unable to adhere to protocol requirements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Portiuncula University Hospital Ballinasloe Ireland
2 Mayo University Hospital Castlebar Ireland
3 Our Lady of Lourdes Hospital Drogheda Drogheda Ireland
4 Beaumont Hospital Dublin Ireland
5 Mater Misericordiae University Hospital Dublin Ireland
6 St James's Hospital Dublin Ireland
7 University Hospital Galway Galway Ireland
8 Letterkenny University Hospital Letterkenny Ireland
9 University Hospital Limerick Limerick Ireland
10 Sligo University Hospital Sligo Ireland
11 University hospital Kerry Tralee Ireland
12 University Hospital Waterford Waterford Ireland

Sponsors and Collaborators

  • Royal College of Surgeons, Ireland

Investigators

  • Principal Investigator: Claire Donohoe, PhD, FRCSI, Trinity College Dublin /Royal College of Surgeons

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Royal College of Surgeons, Ireland
ClinicalTrials.gov Identifier:
NCT05977816
Other Study ID Numbers:
  • RCSI 22-092
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Royal College of Surgeons, Ireland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023